GEN Exclusives

More »

GEN News Highlights

More »
Sep 19, 2006

Bentley Inks Deal with Cardinal Health

  • Bentley Pharmaceuticals secured capacity at Cardinal Health’s new North Raleigh, NC-based facility for the scaleup and manufacture of clinical supplies of Bentley’s intranasal insulin product candidate.

    The product candidate utilizes Bentley’s CPE-215® drug delivery technology to deliver insulin directly through diabetic patients’ nasal mucosa using a nasal spray.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?